NO903169L - 4,1,2-1h-benzoksadiaziner og deres fremstilling. - Google Patents

4,1,2-1h-benzoksadiaziner og deres fremstilling.

Info

Publication number
NO903169L
NO903169L NO90903169A NO903169A NO903169L NO 903169 L NO903169 L NO 903169L NO 90903169 A NO90903169 A NO 90903169A NO 903169 A NO903169 A NO 903169A NO 903169 L NO903169 L NO 903169L
Authority
NO
Norway
Prior art keywords
benzoxadiazines
preparation
Prior art date
Application number
NO90903169A
Other languages
English (en)
Other versions
NO903169D0 (no
Inventor
Jean-Luc Malleron
Daniel Mansuy
Daniel Varech
Guyen Thie-Vuong N
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO903169D0 publication Critical patent/NO903169D0/no
Publication of NO903169L publication Critical patent/NO903169L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C07D253/10Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO90903169A 1989-07-17 1990-07-16 4,1,2-1h-benzoksadiaziner og deres fremstilling. NO903169L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8909590A FR2649612A1 (fr) 1989-07-17 1989-07-17 Medicaments a base de derives de 1h-benzoxadiazine-4,1,2 nouveaux derives et leurs procedes de preparation

Publications (2)

Publication Number Publication Date
NO903169D0 NO903169D0 (no) 1990-07-16
NO903169L true NO903169L (no) 1991-01-18

Family

ID=9383843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903169A NO903169L (no) 1989-07-17 1990-07-16 4,1,2-1h-benzoksadiaziner og deres fremstilling.

Country Status (8)

Country Link
EP (1) EP0410834A1 (no)
JP (1) JPH0352876A (no)
CA (1) CA2021250A1 (no)
FI (1) FI903589A0 (no)
FR (1) FR2649612A1 (no)
IE (1) IE902587A1 (no)
NO (1) NO903169L (no)
PT (1) PT94729A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001866A (en) * 1995-10-05 1999-12-14 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
US6077869A (en) * 1998-10-29 2000-06-20 Ortho-Mcneil Pharmaceutical, Inc. Aryl phenylhydrazides as selective COX-2 inhibitors for treatment of inflammation
EP2314295B1 (en) * 2005-07-29 2015-01-28 Resverlogix, Inc Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
US8053440B2 (en) 2007-02-01 2011-11-08 Resverlogix Corporation Compounds for the prevention and treatment of cardiovascular diseases
ES2542835T3 (es) 2009-01-08 2015-08-12 Resverlogix Corporation Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
BRPI1009315B8 (pt) 2009-03-18 2021-05-25 Resverlogix Corp composto anti-flamatórios e suas composições farmacêuticas
TR201818390T4 (tr) 2009-04-22 2019-01-21 Resverlogix Corp Yeni̇ anti̇-i̇nflamatuvar ajanlar
PL2773354T3 (pl) 2011-11-01 2019-12-31 Resverlogix Corp. Doustna formulacja o natychmiastowym uwalnianiu dla podstawowych chinazolinów
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
CA2895905A1 (en) 2012-12-21 2014-06-26 Zenith Epigenetics Corp. Novel heterocyclic compounds as bromodomain inhibitors
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
CN114349656B (zh) * 2022-01-18 2024-03-29 赣南师范大学 一种酰肼类化合物的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH487171A (de) * 1963-10-22 1970-03-15 Siegfried Ag Verfahren zur Herstellung therapeutisch wirksamer 1,2-Dihydro-1,2,4-benztriazine

Also Published As

Publication number Publication date
PT94729A (pt) 1991-03-20
FR2649612A1 (fr) 1991-01-18
FI903589A0 (fi) 1990-07-16
NO903169D0 (no) 1990-07-16
CA2021250A1 (fr) 1991-01-18
JPH0352876A (ja) 1991-03-07
IE902587A1 (en) 1991-02-27
EP0410834A1 (fr) 1991-01-30

Similar Documents

Publication Publication Date Title
NO902661D0 (no) Ribozymer, deres fremstilling og anvendelse.
DK374389D0 (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
NO900469D0 (no) Piperidinforbindelser, deres fremstilling og anvendelse.
NO912960D0 (no) Polylaktider, deres fremstilling og anvendelse.
NO875358L (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
DK462187A (da) Pyridinyl-pyrimidin-derivater, deres fremstilling og anvendelse.
NO870512L (no) 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling.
NO902279L (no) Benzocykloalkanderivater og deres fremstilling.
NO903169D0 (no) 4,1,2-1h-benzoksadiaziner og deres fremstilling.
DK388989A (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
NO903096D0 (no) Termotrope semialifatiske kopolyesteramider og deres fremstilling.
NO903978L (no) Pyridinyl-kinolonforbindelser, deres fremstilling og bruk.
DK435289A (da) Piperazindioner, deres fremstilling og anvendelse
NO900943D0 (no) Kopolymerer, fremgangsmaate for deres fremstilling og anvendelse.
NO912271D0 (no) Somatostatinpreparater, deres fremstilling og anvendelse.
DK225089A (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
NO164652C (no) Polyfluoralkyltiometyl forbindelser, deres fremstilling og anvendelse.
NO924343L (no) Substituerte 1,5 pentandioler og deres fremstilling
NO892570L (no) Polysilazaner, deres fremstilling og anvendelse.
NO874926D0 (no) Kopolymerer, deres fremstilling og anvendelse.
DK388986A (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-en-derivater, deres fremstillingog anvendelse
DK592389D0 (da) Penemderivater, deres fremstilling og anvendelse
NO901199D0 (no) Azol-1-alkanamider og deres fremstilling.
NO872885L (no) 1,3,5-tritianderivater og fremgangsmŸte for deres fremstilling.
NO885020D0 (no) Isokinolinderivater, deres fremstilling og anvendelse.